Commenting ahead of its upcoming health claims workshop for companies on 11 October in Brussels, EAS Regulatory Affairs Manager Stefanie Geiser said that companies adapting labelling or developing new products must be aware of the differences in interpretation becoming more and more apparent across Member States.